Graypoint LLC’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$859K Sell
8,829
-2,022
-19% -$160K 0.05% 235
2025
Q1
$789K Buy
10,851
+1,022
+10% +$80.5K 0.05% 240
2024
Q4
$710K Buy
9,829
+639
+7% +$48.5K 0.04% 242
2024
Q3
$750K Sell
9,190
-390
-4% -$33.9K 0.05% 230
2024
Q2
$1.02M Buy
9,580
+1,080
+13% +$104K 0.07% 176
2024
Q1
$826K Buy
8,500
+280
+3% +$24.6K 0.06% 203
2023
Q4
$644K Buy
8,220
+1,070
+15% +$72.9K 0.05% 218
2023
Q3
$448K Buy
7,150
+450
+7% +$29.6K 0.04% 254
2023
Q2
$431K Buy
6,700
+800
+14% +$45.1K 0.04% 245
2023
Q1
$313K Buy
+5,900
New +$290K 0.03% 281

Other funds holding LRCX

Graypoint LLC's LRCX Position: Q2 2025 in Review

Graypoint LLC reduced its Lam Research (LRCX) stake by 19% in Q2 2025, selling an estimated $160K and leaving 8,829 shares worth $859K. The position accounts for 0.05% of the portfolio, ranked #235.

Graypoint LLC first reported a position in LRCX in Q1 2023 and has held it in 10 quarters since. The position peaked at $1.02M in Q2 2024. 1,878 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.

  • Graypoint LLC held 8,829 shares of Lam Research worth $859K as of Q2 2025.
  • Graypoint LLC sold 2,022 Lam Research shares in Q2 2025, an estimated $160K.
  • Lam Research made up 0.05% of Graypoint LLC's portfolio in Q2 2025, its #235 holding.
  • Graypoint LLC first reported a position in Lam Research in Q1 2023 and has held it in 10 quarters since.
  • Graypoint LLC's Lam Research position peaked at $1.02M in Q2 2024.
  • 1,878 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.

Based on Graypoint LLC's 13F filing for Q2 2025, filed 15 Jul 2025.